Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2022-06-07
Summary
The study will compare the postprandial responses to a test meal between subjects with type 1 diabetes and healthy control subjects, in terms of gut hormone levels, meal induced thermogenesis, hunger and satiety perception, as well as futher metabolic parameters.
Conditions
- type1diabetes
- Hunger
- Obesity
Interventions
- DIAGNOSTIC_TEST
-
Standardized test meal
A test meal of \~700 kcal consisting of protein and fat will be consumed within 10 minutes
Sponsors & Collaborators
-
National and Kapodistrian University of Athens
lead OTHER
Principal Investigators
-
Alexandros Kokkinos · First Department of Propaedeutic Medicine, Laiko General Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-25
- Primary Completion
- 2022-12-30
- Completion
- 2023-12-30
Countries
- Greece
Study Locations
More Related Trials
-
Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus
NCT07319286 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
Individualised Postprandial Glucose Responses in Type 1 Diabetes
NCT05231642 ·Status: COMPLETED ·Phase: NA
-
Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus
NCT00832741 ·Status: COMPLETED
-
A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects
NCT00884091 ·Status: COMPLETED
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment
NCT04177303 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Main Determinants of Postprandial Glucose Response in Type 1 Diabetes
NCT05936242 ·Status: RECRUITING
-
Effect of High Fat High Protein Meal in Type 1 Diabetes
NCT07158385 ·Status: COMPLETED ·Phase: NA
-
Study of Postprandial Incretin Response in Women With Gestational Diabetes
NCT01274052 ·Status: COMPLETED
-
Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 Diabetes
NCT03556098 ·Status: COMPLETED ·Phase: NA
-
Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes
NCT04079881 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents
NCT06588504 ·Status: COMPLETED ·Phase: PHASE1
-
Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes
NCT04449692 ·Status: COMPLETED ·Phase: PHASE2
-
Very Low Carbohydrate Diets and Glucagon Response in T1DM
NCT04200391 ·Status: RECRUITING ·Phase: NA
-
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
NCT02010827 ·Status: COMPLETED
-
Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?
NCT03954873 ·Status: COMPLETED ·Phase: NA
-
The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes
NCT00732602 ·Status: COMPLETED ·Phase: NA
-
Fats And Carbohydrates Quality on Postprandial glycemIc Response in Type 1 Diabetes
NCT02330939 ·Status: UNKNOWN ·Phase: NA
-
The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes
NCT03734718 ·Status: COMPLETED ·Phase: NA
-
Eating Disturbances in Patients With Type 1 Diabetes Initiating Insulin Therapy
NCT07151924 ·Status: ACTIVE_NOT_RECRUITING
-
GLP-1 Signaling in Truncally Vagotomized Subjects
NCT02940184 ·Status: UNKNOWN ·Phase: NA
-
The Effect of GLP-1 on the Inhibition of Glucagon Secretion
NCT01507597 ·Status: COMPLETED ·Phase: NA
-
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
NCT03139305 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Anatomical Location, Cellular Origin and Molecular Basis of Gut-derived Glucagon Secretion
NCT03181191 ·Status: COMPLETED ·Phase: NA
-
Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176890 ·Status: UNKNOWN ·Phase: NA